c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein

Molecular and Cellular Biology

Volumn 16, Issue 12, 1996, Pages 7054-7062

  Zhu, Jiangyu ^a   Shore, Scott K ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL PROTEIN; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ARTICLE; CELL TRANSFORMATION; ENZYME ACTIVITY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; PROTO ONCOGENE; SEQUENCE HOMOLOGY;

EID: 0029956391     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.12.7054     Document Type: Article

References (49)

1. Atherton-Fessler, S., F. Liu, B. Gabrielli, M. S. Lee, C. Y. Peng, and H. Piwnica-Worms. 1994. Cell cycle regulation of the p34cdc2 inhibitory kinases. Mol. Biol. Cell 5:989-1001.
2. Cicchetti, P., B. J. Mayer, G. Thiel, and D. Baltimore. 1992. Identification of a protein that binds to the SH3 region of ABL and is similar to Bcr and GAP-rho. Science 257:803-806.
3. Cicchetti, P., A. J. Ridley, Y. Zheng, R. A. Cerione, and D. Baltimore. 1995. 3BP-1, an SH3 domain binding protein, has GAP activity for Rac and inhibits growth factor-induced membrane ruffling in fibroblasts. EMBO J. 14:3127-3135.
4. Cooper, J. A., and B. Howell. 1993. The when and how of Src regulation. Cell 73:1051-1054.
5. Corbin, J. D. 1978. Studies on the properties and mode of action of the purified regulatory subunit of bovine heart adenosine 3′:5′-monophosphate-dependent protein kinase. J. Biol. Chem. 253:3997-4003.
6. Corbin, J. D., S. L. Keely, and C. R. Park. 1975. The distribution and dissociation of cyclic adenosine 3′:5′-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues. J. Biol. Chem. 250:218-225.
7. Dai, Z., and A. M. Pendergast. 1995. ABI-2, a novel SH3-containing protein, interacts with the c-ABL tyrosine kinase and modulates c-ABL transforming activity. Genes Dev. 9:2583-2597.
8. Demaillie, J. G., K. A. Peter, and E. H. Fischer. 1977. Isolation and properties of the rabbit skeletal muscle protein inhibitor of adenosine 3′,5′-monophosphate dependent protein kinases. Biochemistry 16:3080-3086.
9. Faux, M. C., and J. D. Scott. 1996. Molecular glue: kinase anchoring and scaffold proteins. Cell 85:9-12.
10. Feller, S. M., B. Knudsen, and H. Hanafusa. 1994. c-ABL kinase regulates the protein binding activity of c-CRK. EMBO J. 13:2341-2351.
11. Fields, S., and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature (London) 340:245-246.
12. Franz, W. M., P. Berger, and J. Y. J. Wang. 1989. Deletion of an N-terminal regulatory domain of c-ABL tyrosire kinase activates its oncogenic potential. EMBO J. 8:137-147.
13. George, B. C., R. Ren, and D. Baltimore. 1995. Modular binding domains in signal transduction proteins. Cell 80:237-248.
14. Gietz, S. A., A. St. Jean, R. A. Woods, and R. H. Schiestl. 1992. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20:1425.
15. Greenberger, J. S., M. A. Sakakeeny, M. A. Humphries, C. J. Eaves, and R. J. Eckner. 1983. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc. Natl. Acad. Sci. USA 80:2931-2935.
16. Homatmisligil, G. S., P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 271:665-668.
17. Hu, S. H. 1994. Insights into autoregulation from the crystal structure of twitchin kinase. Nature (London) 369:581-584.
18. Jackson, P., and D. Baltimore. 1989. N-terminal mutation activates the leukemogenic potential of the myristoylated form of c-ABL. EMBO J. 8:449-456.
19. Johnson, G. L., and R. R. Vaillancourt. 1994. Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell Biol. 6:230-238.
20. Kemp, B. E., M. W. Parker, S. Hu, T. Tiganis, and C. House. 1994. Substrate and pseudosubstrate interactions with protein kinases: determinants of specificity. Trends Biochem. Sci. 19:440-444.
21. Kemp, B. E., and R. B. Pearson. 1990. Protein kinase recognition sequence. Trends Biochem. Sci. 15:342-346.
22. Kemp, B. E., R. B. Pearson, V. Guerriero, J. C. Bagchi, and A. R. Means. 1987. The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence. J. Biol. Chem. 262:2542-2548.
23. Krueger, J. K., R. C. Padre, and J. T. Stull. 1995. Intrasteric regulation of myosin light chain kinase. J. Biol. Chem. 270:16848-16853.
24. Matsuda, M., S. Tanaka, S. Nagata, A. Kojima, T. Kurata, and M. Shibuta. 1992. Two species of human CRK cDNA encode proteins with distinct biological activities. Mol. Cell. Biol. 12:3482-3489.
25. Matsuoka, M., J.-Y. Kato, R. P. Fisher, D. O. Morgan, and C. J. Sherr. 1994. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14:7265-7275.
26. Mayer, B. J., and D. Baltimore. 1994. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell. Biol. 14:2883-2894.
27. Mayer, B. J., H. Hirai, and R. Sakai. 1995. Evidence that SH2 domains promote processive phosphorylation by protein tyrosine kinases. Curr. Biol. 5:296-305.
28. McWhirter, J. R., D. L. Galasso, and J. Y. J. Wang. 1993. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol. 13:7587-7597.
29. McWhirter, J. R., and J. Y. J. Wang. 1991. Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol. Cell. Biol. 11:1553-1565.
30. Muller, A. J., J. C. Young, A.-M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCRIABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785-1792.
31. Oppi, C., S. K. Shore, and E. P. Reddy. 1987. Nucleotide sequence of testis-derived c-ABL cDNAs: implications for testis-specific transcription and ABL oncogene activation. Proc. Natl. Acad. Sci. USA 84:8200-8204.
32. Payne, M. E. 1988. Calcium/calmodulin-dependent protein kinase. II. Characterization of distinct calmodulin binding and inhibitory domains. J. Biol. Chem. 263:7190-7195.
33. Pendergast, A. M., A. J. Muller, M. H. Havlik, R. Clark, F. McCormick, and O. N. Witte. 1991. Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. Proc. Natl. Acad. Sci. USA 88:5927-5931.
34. Pendergast, A. M., A. J. Muller, M. H. Havlik, Y. Maru, and O. N. Witte. 1991. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66:161-171.
35. Pine, J. 1994. Arresting developments in cell cycle control. Trends Biochem. Sci. 19:143-145.
36. Reddy, E. P., M. J. Smith, and A. Sirnivasan. 1983. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other oncogene products with tyrosine-specific kinase activity. Proc. Natl. Acad. Sci. USA 80:3623-3627.
37. Ren, R., Z. Ye, and D. Baltimore. 1993. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259:1157-1161.
38. Ren, R., Z. S. Ye, and D. Baltimore. 1994. ABL protein-tyrosine kinase selects the CRK adapter as a substrate using SH3-binding sites. Genes Dev. 8:783-795.
39. Rogers, S. R., R. Wells, and M. Rechsteiner. 1986. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368.
40. Shi, Y., K. Ålin, and S. P. Goff. 1995. ABL-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the ABL protein, suppresses v-ABL transforming activity. Genes Dev. 9:2583-2597.
41. Smith, D. B., and G. L. Long. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
42. Sun, T., and N. K. Tonks. 1994. The coordinated action of protein tyrosine phosphatases and kinases in cell signaling. Trends Biochem. Sci. 19:480-484.
43. Van Etten, R. A., J. Debnath, H. Zhou, and J. M. Casasnovas. 1995. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-ABL in vivo and abolishes binding of proline-rich ligands in vitro. Oncogene 10:1977-1988.
44. Walsh, D. A., and D. B. Galss. 1991. Utilization of the inhibitor protein of adenosine cyclic monophosphate-dependent protein kinase, and peptides derived from it, as tools to study adenosine cyclic monophosphate-mcdiated cellular processes. Methods Enzymol. 201:304-316.
45. Wang, J. Y. J. 1993. ABL tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev. 3:35-43.
46. Welch, P. J., and J. Y. J. Wang. 1993. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear C-ABL tyrosine kinase in the cell cycle. Cell 75:779-790.
47. Witt, J. J., and R. J. Roskoski. 1975. Bovine brain adenosine 3′,5′-monophosphate dependent protein kinase. Mechanism of regulatory subunit inhibition of the catalytic subunit. Biochemistry 14:4503-4507.
48. Yi, T., and C. L. Willman. 1989. Cloning of the murine c-FGR protooncogene cDNA and induction of c-FGR expression by proliferation and activation factors in normal bone marrow-derived monocytic cells. Oncogene 4:1081-1087.
49. Zhu, J., P. N. Nabissa, B. Hoffman, D. A. Liebermann, and S. K. Shore. 1996. Activated ABL oncogenes and apoptosis: differing responses of transformed mycloid progenitor cell lines. Blood 87:4368-4375.